GAO to HHS: Learn from COVID mistakes in replacing drug-manufacturing program
The US Department of Health and Human Services (HHS) should apply learnings from failures at its drug-manufacturing centers during COVID-19 as it transitions to a new program, concludes a Government Accountability Office (GAO) report published yesterday. HHS, the primary federal department responsible for public health preparedness, created the Centers for Innovation in Advanced Development and…